Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3067283 | 1.00 | APP (0.48) | APPPPARAPPARGMEN1USP2 | |
| SCHEMBL2833686 | 1.00 | APP (0.48) | APPPPARAPPARGMEN1USP2 | |
| SCHEMBL2833682 | 1.00 | APP (0.48) | APPPPARAPPARGMEN1USP2 | |
| SCHEMBL2902933 | 1.00 | APP (0.48) | APPPPARAPPARGMEN1USP2 | |
| SCHEMBL1421269 | 1.00 | APP (0.48) | APPPPARAPPARGMEN1USP2 | |
| SCHEMBL3067288 | 1.00 | APP (0.48) | APPPPARAPPARGMEN1USP2 | |
| SCHEMBL2831861 | 1.00 | APP (0.48) | APPPPARAPPARGMEN1USP2 | |
| SCHEMBL2829944 | 0.92 | APP (0.52) | APPPPARA | |
| SCHEMBL13328310 | 0.92 | APP (0.52) | APPPPARA | |
| SCHEMBL2829935 | 0.92 | APP (0.52) | APPPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2213652-B1 | Stilbene derivatives and their use for binding and imaging amyloid plaques | UNIV PENNSYLVANIA (US) | 2014-10-22 | — | — | EP | claimed |
| EP-2213652-A1 | Stilbene derivatives and their use for binding and imaging amyloid plaques | The Trustees of The University of Pennsylvania (US) | 2010-08-04 | — | — | EP | claimed |
| US-8981156-B2 | Method for production of F-18 labeled amyloid beta ligands | PIRAMAL IMAGING SA (CH) | 2015-03-17 | — | — | US | disclosed |
| US-20140012032-A1 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS | PIRAMAL IMAGING SA (CH) | 2014-01-09 | — | — | US | disclosed |
| US-20130172620-A1 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS | PIRAMAL IMAGING SA (CH) | 2013-07-04 | — | — | US | disclosed |
| US-8465726-B2 | Stilbene derivatives and their use for binding and imaging amyloid plaques | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2013-06-18 | — | — | US | disclosed |
| WO-2012033374-A2 | SULPHONATE PRECURSOR HAVING A 1,2,3-TRIAZOLIUM SALT, A PRODUCTION METHOD THEREFOR AND AN INTRAMOLECULAR NUCLEOPHILIC FLUORINATION REACTION USING THE SAME | 서강대학교 산학협력단 (KR) | 2012-03-15 | — | — | WO | disclosed |
| US-20110137063-A1 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-06-09 | — | — | US | disclosed |
| US-20110112293-A1 | Purification Strategy for Direct Nucleophilic Procedures | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-05-12 | — | — | US | disclosed |
| EP-2297070-A2 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2011-03-23 | — | — | EP | disclosed |
| US-7858072-B2 | Stilbene derivatives and their use for binding and imaging amyloid plaques | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-12-28 | — | — | US | disclosed |
| WO-2010000409-A2 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-01-07 | — | — | WO | disclosed |
| EP-1841465-A4 | STILBENE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES | UNIV PENNSYLVANIA (US) | 2009-04-01 | — | — | EP | disclosed |
| EP-1838298-A4 | STILBENE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES | UNIV PENNSYLVANIA (US) | 2009-03-04 | — | — | EP | disclosed |
| EP-1841465-A2 | STILBENE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES | The Trustees of The University of Pennsylvania (US) | 2007-10-10 | — | — | EP | disclosed |
| EP-1838298-A2 | STILBENE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES | The Trustees of The University of Pennsylvania (US) | 2007-10-03 | — | — | EP | disclosed |
| US-20060269474-A1 | Stilbene derivatives and their use for binding and imaging amyloid plaques | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2006-11-30 | — | — | US | disclosed |
| US-20060269473-A1 | Stilbene derivatives and their use for binding and imaging amyoid plaques | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2006-11-30 | — | — | US | disclosed |
| WO-2006078384-A2 | STILBENE DERIVATIVES AND THEIR USE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2006-07-27 | — | — | WO | disclosed |
| WO-2006066104-A2 | STILBENE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060269473-A1 | Stilbene derivatives and their use for binding and imaging amyoid plaques | IAPP, APP, APBA1 | APP 2/4885PPARA 1597/4885PPARG 2479/4885 |
| US-20110137063-A1 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS | PFAS, PFKFB2, PFKFB1 | APP 508/4885PPARA 189/4885PPARG 151/4885 |
| US-20060269474-A1 | Stilbene derivatives and their use for binding and imaging amyloid plaques | APP, APBA1, PSEN1 | APP 1/4885PPARA 2095/4885PPARG 3479/4885 |
| US-20140012032-A1 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS | APP, APBA1, BACE1 | APP 1/4885PPARA 2041/4885PPARG 3258/4885 |
| US-20110112293-A1 | Purification Strategy for Direct Nucleophilic Procedures | MLX, SRM, STS | APP 2654/4885PPARA 3691/4885PPARG 4320/4885 |
| US-20130172620-A1 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS | APP, APBA1, BACE1 | APP 1/4885PPARA 1989/4885PPARG 2746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.